Results
|
|
1.
|
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Lancet. 381(9869):836-44, 2013 Mar 9.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I
|
|
|
2.
|
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2023
Citation: - Eurointervention. 19(5):e414-e422, 2023 Aug 07.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
All authors: - Bennett J, Escaned J, Ferdinande B, Garcia-Garcia HM, Haude M, Iglesias JF, Joner M, Olivecrano G, Toelg R, Torzewski J, Toth GG, van der Schaaf RJ, Vermeersch P, Waksman R, Wiemer M, Wlodarczak A
|
|
|
3.
|
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2023
Citation: - Eurointervention. 19(5):e414-e422, 2023 Aug 07.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Escaned J, Ferdinande B, Garcia-Garcia HM, Haude M, Iglesias JF, Joner M, Olivecrano G, Toelg R, Torzewski J, Toth GG, van der Schaaf RJ, Vermeersch P, Waksman R, Wiemer M, Wlodarczak A
|
|
|
4.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
